Ginkgo Bioworks Holdings, Inc.
NYSE:DNA
14.29 (USD) • At close February 4, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Ginkgo Bioworks Holdings, Inc. |
Symbool | DNA |
Munteenheid | USD |
Prijs | 14.29 |
Beurswaarde | 821,373,595 |
Dividendpercentage | 0% |
52-weken bereik | 5.26 - 64.4 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Jason Kelly |
Website | https://www.ginkgobioworks.com |
An error occurred while fetching data.
Over Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)